| Item 8.01. | OTHER EVENTS. |
On March 2, 2007, Oscient Pharmaceuticals Corporation issued a press release announcing that Abbott Canada launched FACTIVE® tablets in Canada for the five-day treatment of acute bacterial exacerbations of chronic bronchitis. A copy of the press release is filed as Exhibit 99.1 to this report and incorporated herein by reference.
| ITEM 9.01. | FINANCIAL STATEMENTS AND EXHIBITS. |
(d) Exhibits
| 99.1 | Press Release issued by Oscient Pharmaceuticals Corporation on March 2, 2007. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| OSCIENT PHARMACEUTICALS CORPORATION | ||
| By: |
/s/ Philippe Maitre | |
| Name: |
Philippe Maitre | |
| Title: |
Senior Vice President and Chief Financial Officer | |
Date: March 5, 2007
